SAN DIEGO, July 14, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new data from the Phase 3 CAHtalyst™ Adult and Pediatric studies showing ...

SAN DIEGO, July 14, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced the presentation of new data from the Phase 3 CAHtalyst™ Adult and Pediatric studies showing ...

By Andy Furman NKyTribune reporter Special moments are always worth the wait. Like birthdays. And Christmas morning. But, how long? For Craig Massey, it took 12 years. That’s how long the 36 ...

Neurocrine Biosciences Presented One-Year Data from Phase 3 CAHtalyst™ Studies Showing Improvements in Weight-Related Effects of Glucocorticoid Treatment at the 2025 Endocrine Society’s Annual Meeting ...

XIT – iShares S&P/TSX Capped Info Tech ETF – Check XIT price, review total assets, see historical growth, and review the analyst rating from Morningstar.

SAN DIEGO, July 15, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced results from a new analysis using real-world data from CAHtalog ®, a comprehensive registry of ...

Find the latest iShares S&P/TSX Capped Information Technology Index ETF (XIT.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.

iShares S&P/TSX Capped Information Technology Index ETF (XIT:CA) dividend summary: yield, payout, growth, announce date, ex-dividend date, payout date and Seeking Alpha Premium dividend score.

Background: The need for glucocorticoid sparing drugs (GCSD) remains an important issue and is an unmet need in the treatment of polymyalgia rheumatica (PMR). Objectives: We therefore assessed the ...